Carla J Greenbaum, MD

Trials

Studies that name Carla J Greenbaum, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT01773707 · CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1

  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Abnormal Glucose Tolerance, Type 1 Diabetes · study chair
• Ph2
  NCT01030861 · Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"

  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
  UC4DK106993 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · fiscal years 2015
  Named on NCT01773707, NCT01030861
• Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)USF: TrialNet UC4-3
  UC4DK117009 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · fiscal years 2017 to 2019
  Named on NCT01773707